Post-earnings recap
Reported
Thu, Jan 28, 2016
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
75%
Eli Lilly's earnings report showed a small beat on EPS, but the stock fell by over 6% in reaction. Investors may be concerned about the lack of revenue information and future guidance. The market's negative response suggests caution among investors regarding the company's near-term outlook despite the positive earnings surprise.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.78 | N/A | +1.30% |
Overall, management expressed confidence in their long-term strategy but acknowledged current market challenges. They emphasized the need for continued innovation.
Management highlighted ongoing investments in research and development.
They noted the importance of upcoming product launches in driving future growth.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—